obsolete rheumatic pneumonia

Rheumatic Pneumonia: An Obsolete Condition

Rheumatic pneumonia, also known as "rheumatic pneumonia" or "neumonía reumática", is an outdated medical term that was once used to describe a specific type of pneumonia associated with rheumatic fever. This condition was characterized by a gradual onset of symptoms, including constitutional and respiratory manifestations.

Historical Context

The concept of rheumatic pneumonia dates back to the early 20th century, when it was commonly described as a complication of acute rheumatic fever (ARF). At that time, it was believed to be a distinct entity from other forms of pneumonia. However, with advancements in medical knowledge and understanding, this condition has largely fallen out of favor.

Key Features

Rheumatic pneumonia was thought to occur more frequently in patients with rheumatic fever than in those with other forms of pneumonia. It was often recognized relatively easily due to its characteristic symptoms and presentation.

Current Understanding

The term

Based on the provided context, it appears that rheumatic pneumonia (RP) is a complication of acute rheumatic fever (ARF). While the exact signs and symptoms may have evolved over time, here are some historical aspects related to RP:

• Traditional association with high mortality rate: Rheumatic pneumonia has been reported for more than a century and was traditionally associated with a high mortality rate [11].
• Primary pulmonary lesions: The existence and specificity of primary pulmonary lesions in RP have remained controversial, as similar features may be seen in ARF with complicating congestive heart failure [11].

It's essential to note that the context provided does not explicitly mention "obsolete" rheumatic pneumonia. However, based on the historical context, it can be inferred that some aspects related to RP might be considered outdated or less relevant in modern medical practice.

If you're looking for more information on current signs and symptoms of rheumatic fever or its complications, I'd be happy to help with a new search query!

Based on the provided context, it appears that there are some outdated diagnostic tests for rheumatic pneumonia that are no longer recommended.

According to search result [3], lung biopsy techniques reported in this study are considered obsolete and may not be reliable for future studies. This suggests that these methods are no longer considered best practices for diagnosing rheumatic pneumonia.

Additionally, search result [4] mentions that the term "atypical pneumonia" is often inaccurate and potentially confusing, which implies that some diagnostic tests associated with this term may also be outdated or unreliable.

It's worth noting that there are more modern and innovative methods being developed and employed to evaluate the diagnostic accuracy of medical tests, as mentioned in search results [5] and [6]. These studies aim to systematically review methods for evaluating diagnostic accuracy when there is a missing or no gold standard.

However, it seems that some older diagnostic tests may still be referenced in literature, but are not recommended for use in current practice. For example, search result [8] mentions the introduction of BAL (bronchoalveolar lavage) in the diagnostic evaluation of ILD (interstitial lung disease), which has expanded the list of ELD (extrapulmonary diseases) that can be diagnosed using this technique.

In summary, while there are some outdated diagnostic tests for rheumatic pneumonia, it's essential to consult more recent and reliable sources for accurate information on current best practices.

Treatment of Obsolete Rheumatic Pneumonia

Rheumatic pneumonia, also known as rheumatoid arthritis-associated interstitial lung disease (RA-ILD), is a serious extra-articular manifestation of rheumatoid arthritis. The treatment approach for obsolete rheumatic pneumonia has evolved over time.

• Discontinuation of Offending Drug: The first step in treating drug-induced lung disease, including obsolete rheumatic pneumonia, is to immediately discontinue the offending drug [15].
• Corticosteroids and Immunomodulators: In the chronic phase, the main treatment for RA-IP (rheumatoid arthritis-interstitial pneumonia) is usually anti-inflammatory therapy using corticosteroids or immunosuppressants [5]. This approach can help manage symptoms and slow disease progression.
• Mycophenolate Mofetil: Traditionally, disease-modifying antirheumatic drugs (DMARDs) such as mycophenolate mofetil have been used to treat RA-ILD. However, the effectiveness of these medications in obsolete rheumatic pneumonia is not well established.
• Nintedanib and Pirfenidone: These two drugs have shown promise in slowing disease progression in idiopathic pulmonary fibrosis (IPF). However, their efficacy in treating obsolete rheumatic pneumonia is still being researched [4].

Important Considerations

It's essential to note that the treatment approach for obsolete rheumatic pneumonia may vary depending on individual patient factors and the specific characteristics of the disease. A comprehensive treatment plan should be developed in consultation with a healthcare professional.

References:

[15] Apr 9, 2019 - The treatment of drug-induced lung disease consists of immediately discontinuing the offending drug and appropriately managing the pulmonary symptoms. [5] by M Faisal · 2021 — Disease-modifying antirheumatic drugs (DMARDs) that have been associated with OP include methotrexate (MTX), leflunomide (LEF), etanercept, ... [4] by M Di Franco · 2017 · Cited by 45 — The drugs used in rheumatic disease can be divided into glucocorticoids, conventional disease-modifying anti-rheumatic drugs (DMARDs) and biological DMARDs.

The differential diagnosis of obsolete rheumatic pneumonia involves considering various conditions that may present similarly to rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Some of the key considerations include:

• Community-acquired pneumonia: This should be considered in view of the rapid symptoms, especially if the patient has a history of smoking or other underlying health conditions [1].
• PCP (Pneumocystis carinii pneumonia): This is a type of pneumonia that can occur in people with weakened immune systems, such as those taking immunosuppressive therapy for rheumatoid arthritis. It should be included in the differential diagnosis of acute-onset diffuse interstitial pneumonia [8].
• MTX (methotrexate) pneumonia: This is a rare but serious complication of methotrexate therapy, which can cause pneumonia-like symptoms.
• TNFα inhibitor–induced pneumonia: Tumor necrosis factor-alpha inhibitors are a type of biologic therapy used to treat rheumatoid arthritis. However, they can also cause pneumonia as a side effect.

Other conditions that may be considered in the differential diagnosis of RA-ILD include:

• Organising pneumonia: This is a type of lung disease that can occur in people with connective tissue diseases or other underlying health conditions.
• Pneumonic-type adenocarcinoma: This is a type of lung cancer that can present similarly to interstitial lung disease.

It's worth noting that the differential diagnosis of RA-ILD requires a comprehensive and multidisciplinary approach, taking into account the patient's clinical presentation, radiographic findings, and pathologic features [13].

References:

[1] Faisal M. (2021) - Differential diagnosis​​ In view of the rapid symptoms, community-acquired pneumonia should be considered that could be triggered due to the ...

[8] Mori S. (2012) - PCP should be included in the differential diagnosis of acute-onset diffuse interstitial pneumonia in RA patients receiving immunosuppressive therapy [131].

[13] RyuJ H, Van Udenet JH, et al. (2010) - Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J.